ABOUT US
Company Introduction
- Company Introduction
- History
History
Since 2016
Evolution from a Medical Product Distribution Specialist into a Comprehensive Medical Distribution, Manufacturing, and R&D Enterprise
-
- 2021 – Present
- Leap Forward Phase through R&D, Manufacturing, and New Businesses
- Signed a Joint Development and Production Agreement for the Cardiovascular Business with KIMAL (UK)
- Acquired IntroBiopharma (Incorporated as a Subsidiary)
-
Completed Surgical Robot Technology Transfer with Korea Aerospace University and Seoul National University Hospital
-
Secured a Domestic Patent for the Surgical Robot 'U-BOT'
-
Inauguration of Yoon-seok Lee as CEO
-
Entered the Cardiovascular Intervention Business
-
Relocated and Expanded to the New Headquarters
-
Renewed the 5-Year Domestic Exclusive Distribution Agreement for Baxter's 'Floseal' (~Feb 2028)
-
Signed a Domestic Exclusive Distribution Agreement for ZimVie (US) Spinal Implants
- Established Subsidiary EasyMedibot Co., Ltd. through Capital Investment, Entering the Surgical Robotics Business
-
Relocated and Expanded the Manufacturing Plant to Bolster Production Infrastructure
-
- 2020
- Business Expansion Phase through Global Networks and IPO
-
Listed on KOSDAQ
-
Completed the Absorbed Merger with IBKS No.10 SPAC
-
Signed an MOU with Seoul St. Mary's Hospital for Innovative Medical Device Development
-
Signed a Supply Agreement for Disposable Medical Consumables with Bastos Viegas (Portugal)
-
Signed a New Agreement for Spinal Endoscopes with RIWO Spine (Germany)
-
Signed a Domestic Exclusive Distribution Agreement with FZIOMED (US) for Oxiplex
-
- 2016 ~ 2019
- Company Foundation Phase through Mergers and Acquisitions (M&A)
-
Completed a Third-Party Allotment Capital Increase of Common Stock with IBK and 11 Other Parties
-
Awarded a Laparoscopic System R&D Project Hosted by the Ministry of Health and Welfare
-
Signed a Consulting Agreement with Jungjin Corporation for Supplying Medical Devices and Pharmaceuticals to Dongguk University Medical Center
-
Acquired a 100% Stake in GSMT Co., Ltd., Incorporating it as a Subsidiary
-
Renewed the 5-Year Domestic Exclusive Distribution Agreement for Baxter's 'Floseal' (Excluding Tertiary Hospitals)
-
Changed the Corporate Name to WSI Co., Ltd.
-
Established World Spine Innovation Co., Ltd.
Sales Trend
